Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
30,723,674
-
Share change
-
+14,193,002
-
Total reported value
-
$174,218,000
-
Put/Call ratio
-
56%
-
Price per share
-
$5.67
-
Number of holders
-
55
-
Value change
-
+$81,216,820
-
Number of buys
-
38
-
Number of sells
-
15
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q4 2019
As of 31 Dec 2019,
Aptose Biosciences Inc. - Common Shares was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,723,674 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, Consonance Capital Management LP, Opaleye Management Inc., DRW Securities, LLC, ORBIMED ADVISORS LLC, Ikarian Capital, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, Point72 Asset Management, L.P., and P.A.W. CAPITAL CORP.
This page lists
56
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.